chr1-172659333-GCCA-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000639.3(FASLG):c.144_146delACC(p.Pro49del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,613,162 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P48P) has been classified as Likely benign.
Frequency
Consequence
NM_000639.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASLG | ENST00000367721.3 | c.144_146delACC | p.Pro49del | disruptive_inframe_deletion | 1/4 | 1 | NM_000639.3 | ENSP00000356694.2 | ||
FASLG | ENST00000340030.4 | c.144_146delACC | p.Pro49del | disruptive_inframe_deletion | 1/3 | 1 | ENSP00000344739.3 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152044Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000170 AC: 42AN: 247688Hom.: 0 AF XY: 0.000216 AC XY: 29AN XY: 134146
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461000Hom.: 2 AF XY: 0.000173 AC XY: 126AN XY: 726792
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74382
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This variant, c.144_146del, results in the deletion of 1 amino acid(s) of the FASLG protein (p.Pro53del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FASLG-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
FASLG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 05, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at